ResearcherUniversity of TurinActive in the last 2 years
Francesca Cordero
Matched on ORCID iD 0000-0002-3143-3330; OpenAlex author ID A5064773200. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 4
- In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector r… Co-author DOI 10.3389/fimmu.2024.1427424↗
- In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. Co-author DOI 10.1136/jitc-2020-001071↗
- Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers12030746↗
- Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. Last author DOI 10.3389/fonc.2019.00115↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rosella Spadi · 4 shared papers, 2019–2024 · strength 0.46
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Francesco Novelli · 4 shared papers, 2019–2024 · strength 0.46
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Claudia Curcio · 2 shared papers, 2020–2024 · strength 0.28
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Paola Cappello · 2 shared papers, 2020–2024 · strength 0.28
- Paper In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T l… DOI 10.3389/fimmu.2024.1427424↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Giorgia Mandili · 3 shared papers, 2019–2020 · strength 0.27
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Paper Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. DOI 10.3389/fonc.2019.00115↗
- Laura Follia · 3 shared papers, 2019–2020 · strength 0.27
- Paper Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Panc… DOI 10.3390/cancers12030746↗
- Paper In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vacci… DOI 10.1136/jitc-2020-001071↗
- Paper Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers. DOI 10.3389/fonc.2019.00115↗
- Silvia Brugiapaglia · 1 shared paper, 2024 · strength 0.18
- Michela Capello · 2 shared papers, 2019–2020 · strength 0.18
- Samir Hanash · 2 shared papers, 2019–2020 · strength 0.18
- Moitza Principe · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.